Compare CNOB & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNOB | ABCL |
|---|---|---|
| Founded | 1982 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 1996 | 2020 |
| Metric | CNOB | ABCL |
|---|---|---|
| Price | $27.43 | $4.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $29.50 | $7.75 |
| AVG Volume (30 Days) | 252.2K | ★ 4.2M |
| Earning Date | 01-30-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.74% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.30 | N/A |
| Revenue | ★ $295,956,000.00 | $35,325,000.00 |
| Revenue This Year | $47.80 | $25.45 |
| Revenue Next Year | $31.81 | $10.07 |
| P/E Ratio | $20.23 | ★ N/A |
| Revenue Growth | ★ 19.03 | 7.17 |
| 52 Week Low | $20.61 | $1.89 |
| 52 Week High | $28.47 | $6.52 |
| Indicator | CNOB | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 60.15 | 58.74 |
| Support Level | $25.78 | $4.08 |
| Resistance Level | $26.95 | $4.66 |
| Average True Range (ATR) | 0.62 | 0.26 |
| MACD | -0.05 | 0.09 |
| Stochastic Oscillator | 90.64 | 64.77 |
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.